Vicapsys Life Sciences, Inc. (VICP)
OTCMKTS · Delayed Price · Currency is USD
1.460
+0.470 (47.47%)
At close: Mar 30, 2026
Vicapsys Life Sciences Market Cap
Vicapsys Life Sciences has a market cap or net worth of $47.26 million as of April 16, 2026.
Market Cap
47.26M
Enterprise Value
47.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.46
Market Cap Chart
Since January 5, 2018, Vicapsys Life Sciences's market cap has increased from 9.76M to 47.26M, an increase of 384.24%. That is a compound annual growth rate of 21.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 47.26M | 147,693,953.13% |
| Dec 10, 2024 | 32.00 | -100.00% |
| Dec 20, 2023 | 87.88M | 1,045.91% |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioStem Technologies | 82.47M |
| Nuo Therapeutics | 72.44M |
| Cell Source | 54.36M |
| Harvard Apparatus Regenerative Technology | 27.64M |
| Arch Biopartners | 23.78M |
| Provectus Biopharmaceuticals | 23.07M |
| Anebulo Pharmaceuticals | 20.39M |
| Oncotelic Therapeutics | 16.04M |